Childbirth-related Post-traumatic Stress Disorder in Switzerland and Understanding Its Relations With Depression, Health Care Renunciation, Coparenting and Parental Burnout: The Swiss Cohort on Traumatic Childbirth and Health

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to investigate the prevalence of Childbirth post-traumatic stress disorder (CB-PTSD) and Childbirth post-traumatic stress symptom (CB-PTSS) in Switzerland, and to analyze the psychological, medical, and social factors linked with CB-PTSD and CB-PTSS, whether they are antecedent factors or further consequences. The main questions it aims to answer are : * The prevalence of CB-PTSS and CB-PTSD in Switzerland, for both mothers and partners (Primary outcome) * The risk and protective factors of CB-PTSD and CB-PTSS (Secondary outcome) * The impact of CB-PTSD and CB-PTSS on the marital and co-parental adjustment and the bonding with the infant (Secondary outcome) * The role of the childbirth experience on the triggering of CB-PTSD and CB-PTSS, including emotional and affective aspects (Secondary outcome) * The social and economic determinants of CB-PTSD and CB-PTSS, including, for example, social support and religion (Secondary outcome) Participants will fill up surveys at four time points: * T1, during the third trimester of pregnancy * T2, at 6 to 12 weeks post-partum * T3, at 6 months post-partum * T4, at 12 months post-partum

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: t
View:

• Women being pregnant in the third pregnancy trimester, or being between 6 to 12 weeks postpartum. Partners are recruited base on the inclusion criteria for mothers.

Locations
Other Locations
Switzerland
Lausanne University Hospital
RECRUITING
Lausanne
Contact Information
Primary
Antje Horsch, Prof.
antje.horsch@chuv.ch
+41213148571
Backup
Valentin Offredi
valentin.offredi@chuv.ch
021 314 92 64
Time Frame
Start Date: 2022-05-01
Estimated Completion Date: 2025-12
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire Vaudois

This content was sourced from clinicaltrials.gov

Similar Clinical Trials